R Don Elsey
CIK 1380742 · CFO, Treasurer & Secretary · last filed 2026-06-15
R Don Elsey is a CFO, Treasurer & Secretary who has filed 52 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BFRGW, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $201.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$201.2K
7
52
-$2.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BFRGW | Director | 8,523 | $0.12 | $1.1K | $0 | 5 | 2026-06-15 |
| OPGEN INC (OPGN) Delisted | Director | 308 | $24.75 | $7.6K | $0 | 4 | 2023-06-09 |
| Lyra Therapeutics, Inc. (LYRA) Delisted | CFO, Treasurer & Secretary | — | $0.70 | — | $0 | 2 | 2021-02-10 |
| OPGEN INC (OPGNW) Delisted | Director | 1,500 | — | — | $0 | 1 | 2019-05-02 |
| SENS | CFO, Secretary and Treasurer | — | $4.91 | — | $0 | 3 | 2018-02-05 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Sr. VP/Chief Financial Officer | — | — | — | $0 | 1 | 2015-01-05 |
| EBS | Chief Financial Officer | 27,379 | $7.31 | $200.1K | -$2.05M | 20 | 2012-03-16 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | BFRGW | Grant (A) | — | $0 | EDGAR |
| 2025-09-29 | BFRGW | Grant (A) | — | $0 | EDGAR |
| 2025-08-26 | BFRGW | Grant (A) | +8,523 | $0 | EDGAR |
| 2023-06-09 | OPGEN INC (OPGN) Delisted | Grant (A) | +1,500 | $0 | EDGAR |
| 2023-05-09 | BFRGW | Grant (A) | — | $0 | EDGAR |
| 2023-04-18 | BFRGW | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | OPGEN INC (OPGN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2022-05-19 | — | Grant (A) | — | $0 | |
| 2021-08-04 | — | Grant (A) | — | $0 | |
| 2021-06-10 | OPGEN INC (OPGN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.